New York · 2025 Regular Session · Bill
A 9583: Establishes a research grant program to fund clinical trials of ibogaine for the treatment of veterans for post-traumatic stress disorder
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 9583 is a bill introduced in the New York House on January 21, 2026. According to its official title, it concerns: Establishes a research grant program to fund clinical trials of ibogaine for the treatment of veterans for post-traumatic stress disorder. Primary sponsor: Robert Smullen (Republican). Most recent recorded action (January 21, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Establishes a research grant program to fund clinical trials of ibogaine for the treatment of veterans for post-traumatic stress disorder; creates a fund to provide monies for the research grant program.
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Robert Smullen | Primary sponsor | Republican | House | 118 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH